Neoantigen Prediction for Precision Immunotherapies
Webinar

Neoantigen Prediction for Precision Immunotherapies 

Learn about the tools and resources researchers use to define, discover, and deploy anti-tumor immunotherapies.

Share

 LIVE Symposium

Friday, February 24, 2023
11:00 AM - 2:00 PM Eastern Time

Researchers develop immunotherapies based on cancer mutations that produce neoantigens. These proteins are unique to tumors and facilitate immune system activation. Researchers predict neoantigens using sequencing methodologies and develop modified immune cells including T cells, NK cells, and dendritic cells. 

In this symposium brought to you by The Scientist’s Creative Services Team, researchers will highlight tools and resources used to hunt for neoantigens and discuss how neoantigen T cell receptors (TCRs) are proving effective in destroying tumors.

Symposium program

11:00 AM – Introduction

11:10 AM – Hitting the target: endogenous T cell responses to pediatric tumor neoantigens

Paul Thomas, PhD

11:45 AM – Drugging intracellular targets with antibodies

David Scheinberg, MD, PhD

12:20 PM – Understanding the fate of neoantigen-specific T cells in cancer

Ingunn Stromnes, PhD

12:55 PM – Tools to interrogate antigen presentation in vivo

Alex Jaeger, PhD

1:30 PM - Open panel Q&A session
Deanna MacNeil from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.

Lisa

Paul Thomas, PhD
Member, St. Jude Faculty
Immunology Department
Comprehensive Cancer Center
St. Jude Graduate School of Biomedical Sciences
St. Jude Children’s Research Hospital

Jie Sun 

David Scheinberg, MD, PhD
Chairman, Center for Experimental Therapeutics
Deputy Director for Therapeutic Discovery
Sloan Kettering Institute
Memorial Sloan Kettering Cancer Center


Ingunn
Ingunn Stromnes, PhD
Assistant Professor
Microbiology and Immunology
University of Minnesota


Alex Jaeger

Alex Jaeger, PhD
Assistant Member, Molecular Oncology
Moffitt Cancer Center


Top Image Credit:

3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo